MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
The deal includes upfront payments, milestone payments and ongoing royalties
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
Multi-ethnic innovation helps all complexions appear clearer and more uniform
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
The composition of ORAAL is protected by a granted patent in India until November 2033
Subscribe To Our Newsletter & Stay Updated
